Category: Prescription Drugs
Global Prescription Drugs
-
Global Myocardial Infarction Market Report by Drug Class (Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics, Thrombolytics), Distribution Channels (Hospitals, Hospital Pharmacies, Drug Stores, Online Drug Stores), Regions and Company Analysis 2024-2032
... Stores), Regions and Company Analysis 2024-2032 Global Myocardial Infarction Market share was valued at US$ 2.02 Billion in 2023. It is anticipated to increase at a CAGR of 6.06% from 2024 to 2032 and be ... Read More
-
Global Cold Sore Treatment (for HSV 1 Virus) Market
... the CAGR of 6.6% in the forecast period of 2024 to 2031. Market Segmentation Global Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, and Others(Non Medicated ... Read More
-
Global Dinoprost Tromethamine Market Report, History and Forecast 2019-2030
... million by 2030, growing at a CAGR of 4.82% during the forecast period 2024-2030. North American market for Dinoprost Tromethamine was valued at US$ 22.90 million in 2023 and will reach US$ 31.07 million by ... Read More
-
Potassium Bromide
... at a CAGR of 6.3% over the period 2023-2030. The U.S. Market is Estimated at $5.9 Million, While China is Forecast to Grow at 9.7% CAGR The Potassium Bromide market in the U.S. is estimated ... Read More
-
2024 Global Forecast for Botulinum Toxin Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Paracetamol Iv Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Pain Management Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Dermatology Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Pharmacy Automation Devices Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Erectile Dysfunction Drugs (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for E-Prescribing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
2024 Global Forecast for Aneurysmal Subarachnoid Hemorrhage Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from ... Read More
-
2024 Global Forecast for Pharmacy Automation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Platelet Aggregation Devices Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
Global Allergic Rhinitis Databank Market Report
... 2029. Perennial Allergic Rhinitis segment is expected to be the highest contributor to this market, with $2,396.7 Million in 2020, and is anticipated to reach $3,946.8 Million by 2029, registering a CAGR of 5.74%. Seasonal ... Read More
-
Global Attention Deficit Hyperactivity Disorder Databank Market Report
... 7.15% from 2021 to 2029. Stimulants segment is expected to be the highest contributor to this market, with $350.6 Million in 2020, and is anticipated to reach $669.0 Million by 2029, registering a CAGR of ... Read More
-
Global Anterior Uveitis Treatment Databank Market Report
... 2023 to 2031. Corticosteroids segment is expected to be the highest contributor to this market, with $97.0 Million in 2022, and is anticipated to reach $125.8 Million by 2031, registering a CAGR of 2.97%. Anti-TNF ... Read More
-
Global Anti-Tumor Drugs Databank Market Report
... 2029. Chemotherapy segment is expected to be the highest contributor to this market, with $234,295.8 Million in 2020, and is anticipated to reach $496,893.9 Million by 2029, registering a CAGR of 8.76%. Hormonal Therapy segment ... Read More
-
Global Medication Management System Databank Market Report
... 2023 to 2031. Clinical Decision Support System Solutions segment is expected to be the highest contributor to this market, with $547.7 Million in 2022, and is anticipated to reach $1,113.3 Million by 2031, registering a ... Read More
-
Global Ophthalmology Drugs Databank Market Report
... 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment ... Read More
-
Global Antiplatelet Databank Market Report.pdf
... to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. Surgical Ligation ... Read More
-
Global Antiplatelet Databank Market Report
... providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market ... Read More
-
Global E-Prescribing Databank Market Report
... segment is expected to be the highest contributor to this market, with $1,822.5 Million in 2022, and is anticipated to reach $11,675.6 Million by 2031, registering a CAGR of 23.06%. Services segment is anticipated to ... Read More
-
Global Myasthenia Gravis Treatment Databank Market Report
... 2023 to 2031. Medication segment is expected to be the highest contributor to this market, with $1,236.8 Million in 2022, and is anticipated to reach $2,125.0 Million by 2031, registering a CAGR of 6.24%. Surgery ... Read More
-
Global Myeloproliferative Disorders Drugs Databank Market Report
... 2023 to 2031. Ph+ CML segment is expected to be the highest contributor to this market, with $6,196.2 Million in 2022, and is anticipated to reach $7,194.7 Million by 2031, registering a CAGR of 1.71%. ... Read More